JP2021503938A5 - - Google Patents

Download PDF

Info

Publication number
JP2021503938A5
JP2021503938A5 JP2020529609A JP2020529609A JP2021503938A5 JP 2021503938 A5 JP2021503938 A5 JP 2021503938A5 JP 2020529609 A JP2020529609 A JP 2020529609A JP 2020529609 A JP2020529609 A JP 2020529609A JP 2021503938 A5 JP2021503938 A5 JP 2021503938A5
Authority
JP
Japan
Prior art keywords
cysteine
cystine
seq
sequence defined
similarity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020529609A
Other languages
English (en)
Japanese (ja)
Other versions
JP7422072B2 (ja
JP2021503938A (ja
Filing date
Publication date
Priority claimed from EP17204978.5A external-priority patent/EP3492582A1/en
Application filed filed Critical
Publication of JP2021503938A publication Critical patent/JP2021503938A/ja
Publication of JP2021503938A5 publication Critical patent/JP2021503938A5/ja
Application granted granted Critical
Publication of JP7422072B2 publication Critical patent/JP7422072B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020529609A 2017-12-01 2018-11-29 細胞培養方法 Active JP7422072B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17204978.5A EP3492582A1 (en) 2017-12-01 2017-12-01 Cell culture methods
EP17204978.5 2017-12-01
PCT/EP2018/083010 WO2019106091A1 (en) 2017-12-01 2018-11-29 Cell culture methods

Publications (3)

Publication Number Publication Date
JP2021503938A JP2021503938A (ja) 2021-02-15
JP2021503938A5 true JP2021503938A5 (https=) 2021-11-04
JP7422072B2 JP7422072B2 (ja) 2024-01-25

Family

ID=60629439

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020529609A Active JP7422072B2 (ja) 2017-12-01 2018-11-29 細胞培養方法

Country Status (14)

Country Link
US (1) US11859203B2 (https=)
EP (2) EP3492582A1 (https=)
JP (1) JP7422072B2 (https=)
KR (1) KR20200092348A (https=)
CN (1) CN111417715B (https=)
BR (1) BR112020010473A2 (https=)
CA (1) CA3083680A1 (https=)
EA (1) EA202091349A1 (https=)
ES (1) ES2963653T3 (https=)
HR (1) HRP20231175T1 (https=)
HU (1) HUE063812T2 (https=)
PL (1) PL3717631T3 (https=)
SG (1) SG11202004935UA (https=)
WO (1) WO2019106091A1 (https=)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods
CN112391350A (zh) * 2020-10-30 2021-02-23 北京双鹭药业股份有限公司 高效表达抗egfr单克隆抗体细胞的筛选培养方法
GB202105424D0 (en) 2021-04-16 2021-06-02 UCB Biopharma SRL Cell culture processes
EP4166651A1 (en) 2021-10-18 2023-04-19 Evonik Operations GmbH Methods and composition to increase cellular glutathione level
WO2023067626A1 (en) * 2021-10-20 2023-04-27 Dr. Reddy's Laboratories Limited A cell culture process to produce an antibody composition
EP4484567A4 (en) * 2022-02-21 2026-04-01 Chugai Pharmaceutical Co Ltd PERFUSION CULTURE METHOD
WO2024024720A1 (ja) * 2022-07-25 2024-02-01 味の素株式会社 細胞培養用の培地

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4927762A (en) 1986-04-01 1990-05-22 Cell Enterprises, Inc. Cell culture medium with antioxidant
EP1482031B1 (en) 1996-08-30 2015-10-28 Life Technologies Corporation Serum-free mammalian cell culture medium, and uses thereof
CN101332157B (zh) * 1998-10-09 2012-01-11 味之素株式会社 半胱氨酸衍生物
KR20050070512A (ko) 2003-12-30 2005-07-07 삼성정밀화학 주식회사 재조합 단백질의 생산성을 증가시키는 무혈청 배지 및동물세포 배양방법
TWI456062B (zh) * 2006-09-13 2014-10-11 Abbvie Inc 細胞培養改良
EP2500415A1 (en) 2006-09-13 2012-09-19 Abbott Laboratories Cell culture improvements
AU2011246502B2 (en) 2010-04-26 2014-08-28 Novartis Ag Improved cell cultivation process
WO2013158275A1 (en) 2012-04-20 2013-10-24 Abbvie Inc. Cell culture methods to reduce acidic species
US20130281355A1 (en) 2012-04-24 2013-10-24 Genentech, Inc. Cell culture compositions and methods for polypeptide production
GB201208367D0 (en) 2012-05-14 2012-06-27 Ucb Pharma Sa Biological product
BR112016027797A2 (pt) 2014-06-18 2017-10-31 Medimmune Llc métodos e meios de cultura de células compreendendo n-acetilcisteína
US11220668B2 (en) * 2016-04-28 2022-01-11 Merck Patent Gmbh Method for reducing the trisulfide level in proteins
EP3492582A1 (en) 2017-12-01 2019-06-05 UCB Biopharma SPRL Cell culture methods

Similar Documents

Publication Publication Date Title
JP2021503938A5 (https=)
CN111417715B (zh) 细胞培养方法
JP2018535196A5 (https=)
JP2023166395A5 (https=)
JP2013056885A5 (https=)
RU2012118636A (ru) Молекула, специфически связывающаяся с rsv
JP2020505017A5 (https=)
NZ622583A (en) Protein formulations and methods of making same
AR040046A1 (es) Anticuerpo neutralizante humano anti-igfr
KR102202476B1 (ko) 세포 배양 배지 및 항체 생산 방법
RU2012131671A (ru) Способ полипептидной модификации для очистки полипептидных мультимеров
JP2020537520A5 (https=)
RU2007117765A (ru) 1, 5-нафтиридиназолидиноны, обладающие cdk1 антипролиферативной активностью
RU2014152006A (ru) Молекулы, связывающие il-6
RU2019143742A (ru) Способы культивирования клеток
US20240360225A1 (en) METHOD FOR PRODUCING ANTI-EGFR ANTIBODY, METHOD FOR IMPROVING AFFINITY FOR Fc¿RIIIa, AND ANTI-EGFR ANTIBODY
JPWO2020231809A5 (https=)
JPWO2018219968A5 (https=)
JP2009535314A5 (https=)
JPS6042395A (ja) ペプチドの臭化シアン開裂改良法
CN1176071C (zh) 制备2-烷硫基苯甲酸衍生物的方法
JPWO2023086817A5 (https=)
JP7051820B2 (ja) 組換えタンパク質の生産プロファイルを改変するための方法
ES2800276T3 (es) Métodos para modular perfiles de producción de proteínas recombinantes
CN115505561A (zh) 一种用于cho细胞的无血清培养基添加剂及其用途